Glooko

By Jonah Comstock October 23, 2018
Update: This article has been updated to clarify potentially misleading claims about Novo Nordisk being first to market. Novo Nordisk has struck a deal with Flex Digital Health, part of the IoT logistics company Flex, formerly known as Flextronics. Novo Nordisk will use Flex's BrightInsight platform, which focuses on managing connectivity and compliance for regulated digital health devices, as it...
DreaMed Diabetes tool gets FDA approval
By Dave Muoio June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the healthcare provider and their type 1 diabetes patients...
By Laura Lovett June 11, 2018
Glooko announced the launch of the new version of its Glooko Web Application platform this morning. The site aims to give users more resources with a streamlined navigation tool and an assortment of diabetes analytics, charts, and graphs.  “We are truly excited to supply PWDs and clinicians with the most comprehensive set of reports and analytics on diabetes data available today,” Sam Wyndbrant,...
By MobiHealthNews May 16, 2018
A free tool against substance abuse. Northwell Health and the Center on Addiction have jointly launched a health care app specifically designed to guide providers when screening patients for substance use disorder. Called the SBIRT (Screening, Brief, Intervention, and Referral to Treatment) for Health Professionals app, the tool contains a standardized set of questions to ask patients when trying...
By Dave Muoio April 10, 2018
Digital diabetes management company Glooko announced today that Russ Johannesson will succeed Rick Altinger as the company’s new CEO. Johannesson previously served as COO of Sharecare, and as chief client officer of OptumHealth. Altinger will stay on as Glooko’s EVP of corporate development. “Digital health solutions have a proven impact for people with chronic diseases like diabetes, and Glooko...
By Dave Muoio March 14, 2018
A six-month pilot program conducted by Sharp Rees-Stealy Medical Group in San Diego found that diabetes patients using Glooko’s care management platform were more engaged with their care and achieved better control of their blood glucose levels, according to a case study released by the company. From April to October 2016, Sharp Rees-Stealy care teams provided access to Glooko's platform to 50...
By Dave Muoio February 14, 2018
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA. The MIDS module allows clinicians to create a customized treatment plan and send it to Type 2 diabetes patients directly through the company’...
By Jonah Comstock July 19, 2017
Oscar Health is working with Humana to offer commercial health insurance to small businesses in a nine-county Nashville, Tenn. area. Tech-saavy insurance startup Oscar is teaming up with incumbent Humana at a time when it’s just begun to expand from the individual market into working with employers through its Oscar for Business unit. Humana will provide licenses to operate in Nashville as well...
By Jeff Lagasse July 17, 2017
Novo Nordisk and Glooko are working together to help people manage diabetes from their phones. The companies have partnered on the Cornerstones4Care Powered by Glooko, an app melding Novo Nordisk’s knowledge of diabetes and personalized patient support with Glooko’s digital platform and data analytics know-how. The idea behind the app is to provide, for people with diabetes, a means of measuring...
By Jonah Comstock June 27, 2017
Diabetes data management company Glooko has raised $35 million in new funding. The company already had strategic investments from Samsung and Medtronic; in this new round the Mayo Clinic and insulin pump maker Insulet join those ranks. Toronto-based Georgian Partners led the round, with participation from existing investors Canaan Partners and Social Capital, in addition to the aforementioned...